Reference number : 172-2025-2026-Q2-1034082, amendment number : , agreement type : C, recipient legal name : Nanil Therapeutics Inc, recipient country : CA, recipient province : AB, recipient city : Calgary|Calgary, recipient postal code : T2L 1Y8, program name english : Industrial Research Assistance Program – Contributions to Firms, program name french : Programme d’aide à la recherche industrielle – Contributions aux entreprises, program purpose english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, program purpose french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, agreement title english : POC of AI-Nano-antibody design and Validation for AD, agreement title french : Conception et validation de nanocorps IA pour la maladie d’Alzheimer (PdC), agreement number : 1034082, agreement value : 75000.0, agreement start date : 2025-09-01, agreement end date : 2026-01-02, description english : Nanil Therapeutics is validating its proprietary BioDesign-AI platform through experimental assessment of AI-generated nanobody sequences targeting tau, a key protein in Alzheimer’s disease., description french : Nanil Therapeutics valide sa plateforme exclusive BioDesign-AI par l’évaluation expérimentale de séquences de nanocorps générées par l’IA ciblant la protéine tau, une protéine clé de la maladie d’Alzheimer., expected results english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, expected results french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, additional information english : nan, additional information french : nan, owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada